Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice following head injury

Regulatory Peptides

Volumn 70, Issue 2-3, 1997, Pages 173-178

  Tanaka, Ken Ichi ^a,b   Ogawa, Norio ^a   Asanuma, Masato ^a   Kondo, Yoichi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Cerebral cortex; Dopamine; Head injury; Mice; Norepinephrine; TRH

Indexed keywords

ACETYLCHOLINE; MONOAMINE; PROTIRELIN;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; BRAIN CORTEX; CONCUSSION; DOPAMINE RELEASE; HEAD INJURY; HORMONE RELEASE; MEDULLA OBLONGATA; MOUSE; NERVE EXCITABILITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; THYROTROPIN RELEASE;

3,4-DIHYDROXYPHENYLACETIC ACID; ACETYLCHOLINE; ANIMALS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CEREBRAL CORTEX; CRANIOCEREBRAL TRAUMA; DOPAMINE; HOMOVANILLIC ACID; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED ICR; NOREPINEPHRINE; THYROTROPIN-RELEASING HORMONE;

ANIMALIA;

EID: 0030755369     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01013-6     Document Type: Article

References (41)

1. Manaka S, Sano K. Effects of thyrotropin-releasing hormone tartrate (TRH-T) on disturbance of consciousness (in Japanese). Igaku-no-Aumi 1977;102:867-9.
2. Ogawa N, Tsukamoto S, Mizuno S, Sindo S, Mori A. Effects of calcium hopantenate on concussion following head injury in mice. ICRS Med Sci 1982;10:512-3.
3. Sano K. Clinical studies on thyrotropin releasing hormone tartrate for the treatment of disturbance of consciousness (in Japanese). Shinkeikenkyu-no-Shinpo 1979;23:184-98.
4. Faden AL. Pharmacological treatment of central nervous system trauma. Pharmacol Toxicol 1996;78:12-7.
5. Metcalf G. TRH: a possible mediator of thermoregulation. Nature 1974;252:310-1.
6. Brown M, Vale W. Central nervous system effects of hypothalamic peptides. Endocrinology 1975;96:1333-6.
7. Wei E, Sigel S, Loh H, Way EL. Thyrotropin-releasing hormone shaking behaviour in rat. Nature 1975;253:739-40.
8. Ogawa N, Hirose Y. TRH receptors in the cerebral nervous system. In: Sobue, I, editor. TRH and Spinocerebellar Degeneration. Amsterdam: Elsevier, 1986:25-31.
9. Miyamoto M, Nagai Y, Narumi S. TRH and its analog (DN-1417): antipentobarbital action and involvement of cholinergic mechanisms. Pharmacol Biochem Behav 1982;17:797-806.
10. Puil E, El-Beheiry H. Anaesthetic suppression of transmitter actions in neocortex. Br J Pharmacol 1990;101:61-6.
11. Tanaka K, Ogawa N, Chou H, Mori A, Yanaihara N. Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice. Regul Pept 1992;38:129-33.
12. Glowinski J, Iversen L. Regional studies of catecholamines in the rat brain. I. J Neurochem 1966;13:655-69.
13. Tanaka K, Ogawa N, Asanuma M, Hirata H, Kondo Y, Nakayama N, Mori A. Effects of the acetylcholinesterase inhibitor ENA-713 on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain. Arch Int Pharmacodyn 1992;38:129-33.
14. Ganong WF, Review of medical physiology, 17th ed. Connecticut:Appleton and Lange, 1995:781.
15. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology, 6th ed. New York: Oxford University Press, 1991:454.
16. Adams JH. The neuropathology of head injuries. In: Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology, vol. 23; Injuries of the Brain and Skull, part I. Amsterdam, 1975:35-65.
17. Symonds CP. Concussion and its sequelae. Lancet 1962;1:1-5.
18. Trabucchi M, Cheney DL, Racagni G, Costa E. Pentobarbital and in vivo turnover rate of acetylcholine in mouse brain and in regions of rat brain. Pharmacol Res Commun 1975;7:81-94.
19. Schmidt DE. Effects of thyrotropin releasing hormone (TRH) on pentobarbital-induced decrease in cholinergic neuronal activity. Commun Psychopharmacol 1977;1:469-73.
20. Yarbrough GG. Studies on the neuropharmacology of thyrotropin releasing hormone (TRH) and new analog. Eur J Pharmacol 1978;48:19-27.
21. Okuda C, Mizobe T, Miyazaki M. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone. Life Sci 1987;40:1293-9.
22. McIntosh TK, Yu T, Gennarelli TA. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J Neurochem 1994;63:1426-33.
23. Dail WG, Feeney DM, Murray HM, Linn RT, Boyeson MG. Responses to cortical injury. II: Widespread depression of the activity of an enzyme in cortex remote from focal injury. Brain Res 1981;211:79-89.
24. Feeney DM, Sutton RL, Boyeson MG, Hovda DA, Dail WG. The locus coeruleus and cerebral metabolism: recovery of function after cortical injury. Physiol Psychol 1985;13:197-205.
25. Feeney DM, Sutton Please supply forename. Pharmacotherapy for recovery of function after brain injury. CRC Crit Rev Neurobiol 1987;3:135-97.
26. Tandian D, Romhanyi R, Hovda DA, Yoshino A, Kawamata T, Badaday NF, Becker DP. Amphetamine enhances both behavior and metabolic recovery following fluid percussion brain injury. J Neurotrauma 1990;9:174.
27. Horst WD, Spirt N. Apossible mechanism for the anti-depressant activity of thyrotropin releasing hormone. Life Sci 1974;15:1073-82.
28. Oka M, Ochi Y, Furukawa K, Ito T, Miura Y, Karasawa T, Kadokawa T. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous system functions. Arzneim Forsch 1989;39:297-303.
29. Ito Y, Ogasawara T, Yamazaki A, Ukai Y, Miura A, Kimura K. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamide, as studied by intracerebral microdialysis. J Pharmacol Exp Ther 1993;268:255-61.
30. Huger F, Patrick G. Effect of concussive head injury on central catecholamine levels and synthesis rates in rat brain regions. J Neurochem 1979;33:89-95.
31. Popoli P, Caporali MG, Carolis AS. Effect of SCH 23390 on thyrotropin-releasing hormone-induced behaviour in rabbits. Eur J Pharmacol 1989;173:211-3.
32. Miyamoto M, Nagawa Y. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats. Eur J Pharmacol 1977;44:143-52.
33. Rastogi RB, Singhal RL, Lapierre YD. Effect of MK-771, a novel TRH analog, on brain dopaminergic and serotonergic systems. Eur J Pharmacol 1981;73:307.
34. Ogawa N, Asanuma M, Kondo Y, Hirata H, Nakayama N, Mori A. Effect of vagotomy on hyperactivity and increased dopamine turnover induced by intraperitoneal administration of thyrotropin-releasing hormone. Brain Res 1994;633:167-70.
35. Markianos M, Seretis A, Kotsou A, Christopoulos M. CSF neurotransmitter metabolites in comatose head injury patients during changes in their clinical state. Acta Neurochir 1996;138:57-9.
36. Sasaki M, Hashizume K, Manaka S, Takakura K. The influence of neurotransmitters on the traumatic unconsciousness, immediate convulsion and mortality in the experimental mice model (in Japanese). Noshinkei 1987;39:983-90.
37. Hennies HH, Flohe L. Effects of the thyroliberin analogue CG 3703 on noradrenergic and serotonergic transmission in rodents. Biochem Pharmacol 1982;31:2430-2.
38. Weiss HR, Milton EB. Role of a-adrenoreceptors in the control of the cerebral blood flow response to hypoxia. Eur J Pharmacol 1988;148:107-13.
39. 3H]glutamate from dentate but not CA1/CA3 slices of rat hippocampus. Neuropharmacology 1986;25:493-8.
40. Stanton PK, Mody I, Heinemann U. A role for N-methyl-D-aspartate receptors in norepinephrine-induced long-lasting potentiation in the dentate gyrus. Exp Brain Res 1989;77:517-30.
41. Nagai Y, Yokohama S, Nagawa Y, Hirooka Y, Nihei N. Blood level and brain distribution of thyrotropin-releasing hormone (TRH) determined by radioimmunoassay after intravenous administration in rats. J Pharmacobiodyn 1980;3:500-6.